Multiple Myeloma Cancer Stem Cells Decreased with Novel Antibody Medi-551
A preliminary clinical study at Johns Hopkins Kimmel…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreA preliminary clinical study at Johns Hopkins Kimmel…
The diagnosis and management of myeloma in the very elderly is…
A research team led by William Matsui, MD, and Carol…
Advocates working to raise awareness and funds for multiple…
A screening study — the largest of its kind…